Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3113 results found
Expand All
Apply All
3113 results found

BIO Comment on EU Compulsory Licensing Legislation
Share
Letters, Testimony & Comments  •  July 31, 2023

Dr. Ted Love on M&A, price controls
Share
Good Day BIO Newsletter  •  July 31, 2023
BIO Chair Dr. Ted W. Love has a must-read op-ed on how recent policy actions would have kept patients from accessing his breakthrough sickle cell treatment. Speaking of policy, the EU has proposed new compulsory licensing rules—we have BIO’s take. (550 words, 2 minutes, 45 seconds)
Read More

BIO Statement to the Senate 340B Bipartisan Working Group on Safeguarding and Strengthening 340B
Share
Letters, Testimony & Comments  •  July 28, 2023
In response to a Request for Information (RFI) from the Senate 340B Bipartisan Working Group, BIO submitted detailed comments on the current status of the program and suggestions for improvements.
Read More

How biotech can enhance national security
Share
Good Day BIO Newsletter  •  July 28, 2023
Ending the week with the role of biotech in national security and curing hepatitis, plus more reading and listening for this hot summer weekend. (521 words, 2 minutes, 36 seconds)
Read More

PBM bills advance in House and Senate
Share
Good Day BIO Newsletter  •  July 27, 2023
More activity on the Hill yesterday on PBMs—catch up below. And no, you’re not imagining that there are more mosquitoes—here’s why that’s a problem. (599 words, 2 minutes, 59 seconds)
Read More

Now is the Time to Seize Bioeconomy Opportunities in Farm Bill
Share
Agriculture & Environment, Food & Farm Innovation  •  Press Release  •  July 26, 2023
The next farm bill offers opportunities to invest in long-term food security, climate resiliency and growing the nation’s burgeoning bioeconomy, according to the Biotechnology Innovation Organization, which has submitted recommendations to the House and Senate agriculture committees as they work to write a new farm bill. “A farm bill centered on innovation stands to incentivize the adoption of cutting-edge technologies and practices, resulting in benefits to the environment and rural economies,” said Beth Ellikidis, BIO’s vice president of agriculture and environment. “Supporting biobased technologies and biobased manufacturing is crucial to agriculture being part of the solution to protecting our climate and fostering energy security.” Specific recommendations in BIO’s statement include the following: Biobased Markets Program—The time is critical, when there is so much innovation and development of biobased products, to increase funding for the Biobased Markets or BioPreferred program, which directs federal agencies to increase purchases of biobased and renewable products. The program has not had a funding increase since it began in the 2002 farm bill. North American Industry Classification System (NAICS)—The farm bill can help to increase use of biobased products by clearly defining them in the NAICS. BIO urges the committees to work with USDA and the Office of Management and Budget to update NAICS codes for renewable chemical manufacturers and producers of biobased products, so that federal agencies can accurately classify and report on procurement of biobased products. Biorefinery Incentives—The federal program to help build or retrofit facilities to produce advanced biofuels, renewable chemicals and other biobased products could be tremendously impactful as demand for these products continues to grow. Congress should increase funding and make administrative improvements to the program, including adding sustainable aviation fuel to the Energy…
Read More

BIO Comments to FDA on Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products, and Devices
Share
Letters, Testimony & Comments  •  July 26, 2023
BIO submitted general comments and specific recommendations to the FDA in response to the agency's request for information. (Docket FDA-2022-D-2870)
Read More

BIO Company Presentation Best Practices
Share
Company presentations are an integral program at BIO's international portfolio of events, allowing companies to present their pipelines, goals, and objectives to a global audience of investors and business development executives.  These videos are designed to provide you with helpful tactics that help you clearly communicate your company's store to key stakeholders. 
Read More

EU approves data sharing with the US
Share
Good Day BIO Newsletter  •  July 26, 2023
The EU approved a framework to support data sharing with the U.S.—here’s what it means for research and collaboration. Plus, creative use of gene therapy gave a boy his sight back—but policy might discourage this kind of innovation. (490 words, 2 minutes, 27 seconds)
Read More

BIO Comments to Centers for Medicare & Medicaid Services, Department of Health and Human Services RE: CMS–2434–P
Share
Letters, Testimony & Comments  •  July 25, 2023
BIO submitted comments to CMS per their Notice of Proposed Rulemaking: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 87
  • 88
  • 89
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO